Insightful Look at Market Trends
Insightful Look at Market Trends
Shares of Cardlytics, Inc. CDLX surged in today’s pre-market trading following the company’s robust fourth-quarter earnings report.
Cardlytics exceeded market expectations by reporting adjusted earnings of 14 cents per share compared to the anticipated 12 cents per share. Additionally, the company forecasted first-quarter revenue in the range of $70 million to $73 million, surpassing the consensus estimate of $66.46 million.
The stock of Cardlytics experienced a significant 36.6% increase, reaching $11.18 in pre-market trading.
Stay informed about other notable stocks making movements in pre-market trading.
Gaining Momentum
- Fisker Inc. FSR saw a rise of 31.3% to $0.2034 following a substantial dip of 52% the day before.
- Madrigal Pharmaceuticals, Inc. MDGL surged 26.9% to $309.13 after receiving FDA approval for Rezdiffra.
- 2seventy bio, Inc. TSVT climbed 18.7% to $4.70 despite recent disappointing quarterly results.
- American Vanguard Corporation AVD rose 16% to $12.28 following its fourth-quarter financial report.
Facing Challenges
- Kopin Corporation KOPN dropped 14.6% to $1.87 after disappointing fourth-quarter results.
- Smartsheet Inc. SMAR fell 11.8% to $35.56 due to lower-than-expected revenue guidance for FY25.
- Adobe Inc. ADBE dipped 11.3% to $505.88 following a weak revenue outlook for the upcoming quarter.
- Psyence Biomedical Ltd. PBM experienced a 10.6% decline to $1.42 after substantial gains the previous day.
Follow the market flux with keen interest as various stocks navigate the dynamic landscape of pre-market trading.
Shares of Cardlytics, Inc. CDLX surged in today’s pre-market trading following the company’s robust fourth-quarter earnings report.
Cardlytics exceeded market expectations by reporting adjusted earnings of 14 cents per share compared to the anticipated 12 cents per share. Additionally, the company forecasted first-quarter revenue in the range of $70 million to $73 million, surpassing the consensus estimate of $66.46 million.
The stock of Cardlytics experienced a significant 36.6% increase, reaching $11.18 in pre-market trading.
Stay informed about other notable stocks making movements in pre-market trading.
Gaining Momentum
- Fisker Inc. FSR saw a rise of 31.3% to $0.2034 following a substantial dip of 52% the day before.
- Madrigal Pharmaceuticals, Inc. MDGL surged 26.9% to $309.13 after receiving FDA approval for Rezdiffra.
- 2seventy bio, Inc. TSVT climbed 18.7% to $4.70 despite recent disappointing quarterly results.
- American Vanguard Corporation AVD rose 16% to $12.28 following its fourth-quarter financial report.
Facing Challenges
- Kopin Corporation KOPN dropped 14.6% to $1.87 after disappointing fourth-quarter results.
- Smartsheet Inc. SMAR fell 11.8% to $35.56 due to lower-than-expected revenue guidance for FY25.
- Adobe Inc. ADBE dipped 11.3% to $505.88 following a weak revenue outlook for the upcoming quarter.
- Psyence Biomedical Ltd. PBM experienced a 10.6% decline to $1.42 after substantial gains the previous day.
Follow the market flux with keen interest as various stocks navigate the dynamic landscape of pre-market trading.
